| All cancers | Radiologist-positive cancers | AI-positive cancers | P value |
---|---|---|---|---|
Total number of cancers | 143 | 100 | 96 | 0.610 |
Age (years) | 46.6 (9.2) | 47.8 (9.5) | 46.5 (9.6) | 0.096 |
Cancer type | Â | Â | Â | Â |
 Ductal carcinoma in situ | 35 (24.5) | 31 (31.0) | 23 (23.9) | 0.038 |
 Invasive | 108 (75.5) | 69 (69.0) | 73 (76.0) | 0.038 |
SEER | Â | Â | Â | Â |
 Localized | 108 (75.5) | 78 (78.0) | 68 (70.8) | 0.577 |
 Regional | 31 (21.7) | 20 (20.0) | 26 (27.1) | 0.284 |
 Distant | 1 (0.7) | 0 (0.0) | 0 (0.0) | - |
 Unknown | 3 (2.1) | 2 (2.0) | 2 (2.1) | 0.921 |
Treatment modality | Â | Â | Â | Â |
 Surgery | 129 (90.2) | 90 (90.0) | 84 (87.5) | 0.199 |
 Chemotherapy | 52 (36.4) | 31 (31.0) | 38 (39.6) | 0.515 |
 Radiotherapy | 38 (26.6) | 24 (24.0) | 21 (21.9) | 0.049 |
 Hormone therapy | 32 (22.4) | 19 (19.0) | 18 (18.8) | 0.044 |
 No treatment | 4 (2.8) | 3 (3.0) | 3 (3.1) | 0.672 |
Time to cancer diagnosis since screening mammography (months)* | 2.46 (0.95–9.26) | 1.54 (0.69–5.21) | 1.54 (0.66–5.17) | < 0.001 |
Mammographic density | Â | Â | Â | Â |
 Non-dense | 18 (12.6) | 14 (14.0) | 14 (14.6) | 0.164 |
 Dense | 125 (87.4) | 86 (86.0) | 82 (85.4) | 0.164 |
Mammography density | Â | Â | Â | Â |
 Almost entirely fatty | 2 (1.4) | 1 (1.0) | 1 (1.0) | 0.455 |
 Scattered fibroglandular tissue | 16 (11.2) | 13 (13.0) | 13 (13.5) | 0.058 |
 Heterogeneously dense | 66 (46.2) | 50 (50.0) | 42 (43.8) | 0.663 |
 Extremely dense | 59 (41.3) | 36 (36.0) | 40 (41.7) | 0.198 |
Mammographic density-AI | Â | Â | Â | Â |
 A | 1 (0.7) | 1 (1.0) | 1 (1.0) | - |
 B | 23 (16.1) | 19 (19.0) | 17 (17.7) | 0.082 |
 C | 91 (63.6) | 63 (63.0) | 57 (59.4) | 0.210 |
 D | 28 (19.6) | 17 (17.0) | 32 (21.9) | 0.876 |